e-learning
resources
London 2016
Monday, 05.09.2016
Pulmonary hypertension in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary arterial hypertension and continuous injury of alveolar epithelial cells in COPD
Kenji Yazaki (Yuri-Honjo, Japan), Kenji Yazaki, Naoko Kamada
Source:
International Congress 2016 – Pulmonary hypertension in lung disease
Session:
Pulmonary hypertension in lung disease
Session type:
Thematic Poster
Number:
2440
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kenji Yazaki (Yuri-Honjo, Japan), Kenji Yazaki, Naoko Kamada. Pulmonary arterial hypertension and continuous injury of alveolar epithelial cells in COPD. Eur Respir J 2016; 48: Suppl. 60, 2440
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Endothelial progenitor cells and pulmonary vascular remodeling in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 435s
Year: 2004
Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007
Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle cells
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with
BMPR2
mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Pulmonary hypertension in chronic lung disease and hypoxia
Source: Eur Respir J, 53 (1) 1801914; 10.1183/13993003.01914-2018
Year: 2019
Comparison of current therapies against endothelin-induced growth in pulmonary smooth arterial muscle cells (PASMCs) derived from patients with pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Pulmonary hypertension and endothelial dysfunction in patients with bronchial asthma
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Treatment of pulmonary hypertension in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313
Year: 2006
Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Circulating endothelial progenitor cells and chronic pulmonary diseases
Source: Eur Respir J 2011; 37: 426
Year: 2011
Pulmonary hypertension in interstitial lung diseases
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Small airways dysfunction in chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Dyspnoea and respiratory muscle mechanics dysfunction in disease
Year: 2015
Pulmonary vessels remodeling in COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Pulmonary hypertension due to lung disease
Source: International Congress 2017 – Russian Programme 2017
Year: 2017
IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Pulmonary hypertension in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 892-905
Year: 2003
Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept